Différences
Ci-dessous, les différences entre deux révisions de la page.
| Les deux révisions précédentes Révision précédente | Prochaine révisionLes deux révisions suivantes | ||
| ecolopol:covid19 [2020/04/17 16:42] – [Progression de la recherche et suivi de la pandémie] Grégory Gutierez | ecolopol:covid19 [2020/04/18 09:27] – [Suivi de la recherche face au SARS-CoV2] Grégory Gutierez | ||
|---|---|---|---|
| Ligne 243: | Ligne 243: | ||
| ^[[https:// | ^[[https:// | ||
| |In this uncontrolled case series of 5 critically ill patients with COVID-19 and acute respiratory distress syndrome (ARDS), administration of convalescent plasma containing neutralizing antibody was followed by an improvement in clinical status.||| | |In this uncontrolled case series of 5 critically ill patients with COVID-19 and acute respiratory distress syndrome (ARDS), administration of convalescent plasma containing neutralizing antibody was followed by an improvement in clinical status.||| | ||
| + | |||
| + | ^[[https:// | ||
| + | |In the midst of the global COVID-19 public-health emergency, it is reasonable to wonder why the origins of the pandemic matter. Detailed understanding of how an animal virus jumped species boundaries to infect humans so productively will help in the prevention of future zoonotic events. For example, if SARS-CoV-2 pre-adapted in another animal species, then there is the risk of future re-emergence events. In contrast, if the adaptive process occurred in humans, then even if repeated zoonotic transfers occur, they are unlikely to take off without the same series of mutations. In addition, identifying the closest viral relatives of SARS-CoV-2 circulating in animals will greatly assist studies of viral function.||| | ||
| ^[[https:// | ^[[https:// | ||